Cost-Effectiveness of Continuous Subcutaneous Insulin Infusion Versus Multiple Daily Injections in Patients with Poorly Controlled Type 2 Diabetes in Finland

INTRODUCTION: Although primarily utilized in type 1 diabetes, continuous subcutaneous insulin infusion (CSII) represents a useful treatment alternative for patients with type 2 diabetes who are unable to achieve good glycemic control despite optimization of multiple daily injections (MDI). The aim o...

Descripción completa

Detalles Bibliográficos
Autores principales: Roze, Stephané, Smith-Palmer, Jayne, Delbaere, Alexis, Bjornstrom, Karita, de Portu, Simona, Valentine, William, Honkasalo, Mikko
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Healthcare 2019
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6437241/
https://www.ncbi.nlm.nih.gov/pubmed/30730036
http://dx.doi.org/10.1007/s13300-019-0575-9

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6437241/
https://www.ncbi.nlm.nih.gov/pubmed/30730036
http://dx.doi.org/10.1007/s13300-019-0575-9

Ejemplares similares